GlassScriptPhysician profile
Ida Williams
NPI 1790848620
$665.82
in general payments reported to CMS, 2019-2025
14 companies · $213 in 2025
The $213 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.90 · 2020: $30.06 · 2021: $13.19 · 2022: $170 · 2023: $72.22 · 2024: $123 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $183.14 | 2019-2025 | Bexsero, Shingrix, Arexvy |
| Evoke Pharma, INC. | $125.00 | 2022 | |
| Exact Sciences Corporation | $81.01 | 2023-2025 | Cologuard Collection Kit |
| Alkermes, INC. | $76.77 | 2025 | Vivitrol |
| Sanofi Pasteur INC. | $30.45 | 2019-2024 | |
| Insulet Corporation | $25.00 | 2024 | Omnipod |
| Hologic Sales and Service, LLC | $24.45 | 2025 | Aptima |
| Vbi Vaccine (Delaware) INC. | $22.06 | 2023 | Prehevbrio |
| Merck Sharp & Dohme LLC | $21.93 | 2025 | Vaxneuvance, Enflonsia, Gardasil 9 |
| Gilead Sciences, INC. | $18.69 | 2020 | |
| Medtronic, INC. | $17.33 | 2024 | Minimed 780g |
| Cranial Technologies, INC | $16.24 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.38 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $11.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ida Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.